Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema

Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema - Clinical study of mixed formulation with corticosteroid and moisturizer for asteatotic eczema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026052

Enrollment

Registered

2017-03-01

Start date

2017-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asteatotic eczema

Interventions

steroid ointment and steroid containing moisturizer 7days and 14 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Older than 20yo. agree to participate in this trial. person with asteatotic eczema distributed symmetrically.

Exclusion criteria

Exclusion criteria: Person with allergic dermatitis other than asteatotic eczema. Person with bacterial skin infection. Sever atopic dermatitis patient. Person who has hypersensitivity for steroid or steroid containing moisturizer Person who enrolled in other clinical trial within a month. Person who was disqualified by principal clinician.

Design outcomes

Primary

Measure	Time frame
disease severity after application for 2weeks.	—

Secondary

Measure	Time frame
itching score, skin surface hydration, sweating, texture of skin	—

Countries

Japan

Contacts

Public ContactYumi Aoyama

Department of dermatology, Kawasaki Medical School, 577 Matsushima Kurashiki city, Okayama Japan Dermatology

kmsrec@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026